GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Icure Pharmaceutical Inc (XKRX:175250) » Definitions » Cyclically Adjusted PB Ratio

Icure Pharmaceutical (XKRX:175250) Cyclically Adjusted PB Ratio : 0.68 (As of May. 09, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Icure Pharmaceutical Cyclically Adjusted PB Ratio?

As of today (2025-05-09), Icure Pharmaceutical's current share price is ₩1980.00. Icure Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was ₩2,918.42. Icure Pharmaceutical's Cyclically Adjusted PB Ratio for today is 0.68.

The historical rank and industry rank for Icure Pharmaceutical's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:175250' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.51   Med: 0.62   Max: 0.85
Current: 0.7

During the past years, Icure Pharmaceutical's highest Cyclically Adjusted PB Ratio was 0.85. The lowest was 0.51. And the median was 0.62.

XKRX:175250's Cyclically Adjusted PB Ratio is ranked better than
79.69% of 635 companies
in the Drug Manufacturers industry
Industry Median: 1.67 vs XKRX:175250: 0.70

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Icure Pharmaceutical's adjusted book value per share data for the three months ended in Dec. 2024 was ₩1,612.532. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩2,918.42 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Icure Pharmaceutical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Icure Pharmaceutical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icure Pharmaceutical Cyclically Adjusted PB Ratio Chart

Icure Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.62

Icure Pharmaceutical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.71 0.62

Competitive Comparison of Icure Pharmaceutical's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Icure Pharmaceutical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Icure Pharmaceutical's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Icure Pharmaceutical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Icure Pharmaceutical's Cyclically Adjusted PB Ratio falls into.


;
;

Icure Pharmaceutical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Icure Pharmaceutical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1980.00/2918.42
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Icure Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Icure Pharmaceutical's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1612.532/121.1352*121.1352
=1,612.532

Current CPI (Dec. 2024) = 121.1352.

Icure Pharmaceutical Quarterly Data

Book Value per Share CPI Adj_Book
201503 0.000 99.721 0.000
201506 0.000 100.051 0.000
201509 0.000 100.111 0.000
201512 510.986 100.220 617.623
201603 442.597 100.561 533.150
201606 857.740 100.791 1,030.874
201609 1,126.627 101.461 1,345.087
201612 1,036.169 101.561 1,235.870
201703 1,038.192 102.851 1,222.760
201706 1,043.923 102.611 1,232.377
201709 904.661 103.491 1,058.902
201712 1,062.809 102.991 1,250.049
201803 1,185.354 104.101 1,379.318
201806 810.223 104.130 942.536
201809 4,209.564 105.651 4,826.540
201812 4,128.533 104.351 4,792.595
201903 4,323.141 104.491 5,011.772
201906 4,470.124 104.881 5,162.898
201909 4,609.257 105.200 5,307.430
201912 4,610.519 105.121 5,312.873
202003 4,516.446 105.354 5,192.964
202006 4,687.739 105.112 5,402.345
202009 4,806.810 106.198 5,482.929
202012 4,513.236 105.765 5,169.098
202103 4,220.064 107.357 4,761.658
202106 3,994.169 107.579 4,497.497
202109 3,715.388 108.759 4,138.172
202112 3,657.721 109.676 4,039.873
202203 3,427.454 111.848 3,712.050
202206 3,070.280 114.072 3,260.379
202209 2,835.820 114.715 2,994.523
202212 2,399.536 115.179 2,523.618
202303 2,206.488 116.507 2,294.132
202306 2,057.804 117.182 2,127.223
202309 1,997.390 118.964 2,033.851
202312 1,558.408 118.837 1,588.545
202403 1,433.339 120.123 1,445.414
202406 1,415.818 120.007 1,429.125
202409 2,008.384 120.861 2,012.937
202412 1,612.532 121.135 1,612.532

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Icure Pharmaceutical  (XKRX:175250) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Icure Pharmaceutical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Icure Pharmaceutical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Icure Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
7, Saimdang-ro 1-gil, Seocho-gu, Seoul, KOR
Icure Pharmaceutical Inc operates as a biopharmaceutical company engages in the development and commercialization of novel transdermal drug delivery formulation. It also developed and commercialized various patches and hydrogels for the treatment of rheumatic arthritis pain, nicotine replacement therapy, medicated wound dressings, skin care, and dental care. The products pipeline is also aimed at the development of prescription drugs to diseases of the central nervous system, asthma, and pain.

Icure Pharmaceutical Headlines

No Headlines